Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis
- PMID: 12556961
- PMCID: PMC2376782
- DOI: 10.1038/sj.bjc.6600688
Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis
Abstract
This study investigated regional variations in the contribution made by different human papilloma (HPV) types to invasive cervical cancer (ICC). A total of 85 studies using polymerase chain reaction to estimate HPV prevalence in ICC were identified. Data on HPV prevalence were extracted separately for squamous cell carcinoma (SCC) and for adeno- and adenosquamous-carcinoma (ADC). A total of 10 058 cases (8550 SCC, 1508 ADC) were included in pooled analyses. The most common HPV types in ICC were, in order of decreasing prevalence, HPV16, 18, 45, 31, 33, 58, 52, 35, 59, 56, 6, 51, 68, 39, 82, 73, 66 and 70. In SCC, HPV16 was the predominant type (46-63%) followed by HPV18 (10-14%), 45 (2-8%), 31 (2-7%) and 33 (3-5%) in all regions except Asia, where HPV types 58 (6%) and 52 (4%) were more frequently identified. In ADC, HPV prevalence was significantly lower (76.4%) than in SCC (87.3%), and HPV18 was the predominant type in every region (37-41%), followed by 16 (26-36%) and 45 (5-7%). The overall detection of HPV DNA was similar in different regions (83-89%). A majority of ICC was associated with HPV16 or 18 in all regions, but approximately a quarter of all ICC cases were associated with one of 16 other HPV types, their distribution varying by region.
Figures



Similar articles
-
Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication.Int J Cancer. 2011 Feb 15;128(4):927-35. doi: 10.1002/ijc.25396. Int J Cancer. 2011. PMID: 20473886
-
Human papillomavirus prevalence and type-specific relative contribution in invasive cervical cancer specimens from Italy.BMC Cancer. 2010 Jun 4;10:259. doi: 10.1186/1471-2407-10-259. BMC Cancer. 2010. PMID: 20525370 Free PMC article.
-
Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix.Cancer Res. 2003 Nov 1;63(21):7215-20. Cancer Res. 2003. PMID: 14612516
-
Human papillomavirus infection and invasive cervical neoplasia: a study of prevalence and morphology.J Pathol. 1997 Mar;181(3):270-5. doi: 10.1002/(SICI)1096-9896(199703)181:3<270::AID-PATH767>3.0.CO;2-R. J Pathol. 1997. PMID: 9155711 Review.
-
A Meta-Analysis on Human Papillomavirus Type Distribution among Women with Cervical Neoplasia in the WHO Eastern Mediterranean Region.Intervirology. 2019;62(3-4):101-111. doi: 10.1159/000502824. Epub 2019 Sep 17. Intervirology. 2019. PMID: 31527382
Cited by
-
Novel epigenetic changes in CDKN2A are associated with progression of cervical intraepithelial neoplasia.Gynecol Oncol. 2016 Sep;142(3):566-73. doi: 10.1016/j.ygyno.2016.07.006. Epub 2016 Jul 9. Gynecol Oncol. 2016. PMID: 27401842 Free PMC article.
-
A cross-sectional, multicentre, epidemiological study on human papillomavirus (HPV) type distribution in adult women diagnosed with invasive cervical cancer in Belgium.Facts Views Vis Obgyn. 2015;7(2):101-8. Facts Views Vis Obgyn. 2015. PMID: 26175888 Free PMC article.
-
Knowledge on HPV Vaccine and Cervical Cancer Facilitates Vaccine Acceptability among School Teachers in Kitui County, Kenya.PLoS One. 2015 Aug 12;10(8):e0135563. doi: 10.1371/journal.pone.0135563. eCollection 2015. PLoS One. 2015. PMID: 26266949 Free PMC article.
-
Cervical human papillomavirus infection and squamous intraepithelial lesions in rural Gambia, West Africa: viral sequence analysis and epidemiology.Br J Cancer. 2005 Oct 31;93(9):1068-76. doi: 10.1038/sj.bjc.6602736. Br J Cancer. 2005. PMID: 16106268 Free PMC article.
-
Assessment of MagNA pure LC extraction system for detection of human papillomavirus (HPV) DNA in PreservCyt samples by the Roche AMPLICOR and LINEAR ARRAY HPV tests.J Clin Microbiol. 2006 Jul;44(7):2428-33. doi: 10.1128/JCM.02608-05. J Clin Microbiol. 2006. PMID: 16825360 Free PMC article.
References
-
- Andersson S, Rylander E, Larsson B, Strand A, Silfversvard C, Wilander E (2001) The role of human papillomavirus in cervical adenocarcinoma carcinogenesis. Eur J Cancer 37: 246–250 - PubMed
-
- Barbosa MS, Schlegel R (1989) The E6 and E7 genes of HPV-18 are sufficient for inducing two-stage in vitro transformation of human keratinocytes. Oncogene 4: 1529–1532 - PubMed
-
- Bernard HU, Chan SY, Manos MM, Ong CK, Villa LL, Delius H, Peyton CL, Bauer HM, Wheeler CM (1994) Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 170: 1077–1085 - PubMed
-
- Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV (1995) Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 87: 796–802 - PubMed
-
- Breslow NE, Day NE (1980) Statistical methods in cancer research. Vol. I – The analysis of case–control studies. IARC Sci Publ 32: 5–338 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials